BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6205946)

  • 21. The treatment of recurrent and metastatic cervical carcinoma. Evaluation of an antiblastic combination of methotrexate-adriamycin-bleomycin (MAB).
    Adamo V; Altavilla G; Buemi B; Caristi N; Scalisi R; Tropea F
    Chemioterapia; 1985 Apr; 4(2):143-6. PubMed ID: 2408771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neoadjuvant chemotherapy in locally advanced squamous carcinoma of the uterine cervix (IB2 - IIIB stage)].
    Kornovski Ia; Ianeva R; Gorchev G; Tsekov Kh; Uzunov S; Filev S
    Akush Ginekol (Sofiia); 2002; 41(4):39-44. PubMed ID: 12516261
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug-related pulmonary toxicity in non-Hodgkin's lymphoma. Comparative results with three different treatment regimens.
    Shapiro CL; Yeap BY; Godleski J; Jochelson MS; Shipp MA; Skarin AT; Canellos GP
    Cancer; 1991 Aug; 68(4):699-705. PubMed ID: 1713121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant chemotherapy in locally advanced cervical carcinoma.
    Mancuso S; Benedetti Panici P; Greggi S; Scambia G
    Contrib Gynecol Obstet; 1989; 17():111-20. PubMed ID: 2468445
    [No Abstract]   [Full Text] [Related]  

  • 25. Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck.
    Clavel M; Cognetti F; Dodion P; Wildiers J; Rosso R; Rossi A; Gignoux B; Van Rymenant M; Cortes-Funes H; Dalesio O
    Cancer; 1987 Sep; 60(6):1173-7. PubMed ID: 2441836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy for advanced and/or recurrent cervical cancer.
    Lahousen M; Pickel H; Tamussino K
    Arch Gynecol; 1987; 240(4):247-52. PubMed ID: 2440389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiblastic treatment of advanced cervical carcinoma and its recurrences: assessment of four different polychemotherapies used for a decade.
    Rigano A; Adamo V; Altavilla G; d'Aquino S
    Eur J Gynaecol Oncol; 1989; 10(4):271-6. PubMed ID: 2476314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC; Fabian RL
    Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bleomycin, vincristine, mitomycin C, and cis-platinum in gynecologic squamous cell carcinomas: a high incidence of pulmonary toxicity.
    Chambers SK; Flynn SD; Del Prete SA; Chambers JT; Schwartz PE
    Gynecol Oncol; 1989 Mar; 32(3):303-9. PubMed ID: 2465939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II trial of cis-diamminedichloroplatinum (cis-platinum), vincristine, and peplomycin for advanced squamous cell carcinoma.
    Tamura K; Araki Y; Tateyama H; Maeda M; Seita M
    J Surg Oncol; 1987 Aug; 35(4):241-4. PubMed ID: 2441207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained complete remission of stage IVb carcinoma of the cervix with cis-platinum, methotrexate and bleomycin chemotherapy.
    Burnet NG; Blake PR
    Br J Radiol; 1989 Sep; 62(741):856-9. PubMed ID: 2477109
    [No Abstract]   [Full Text] [Related]  

  • 32. Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer.
    Panasci L; Gravenor D; Black M; Frenkiel S; Margolese R
    Cancer Treat Rep; 1985 Sep; 69(9):1015-7. PubMed ID: 2411401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma.
    Weiner SA; Aristizabal S; Alberts DS; Surwit EA; Deatherage-Deuser K
    Gynecol Oncol; 1988 May; 30(1):1-6. PubMed ID: 2452769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy of advanced or recurrent cervical carcinoma with a consecutive low-dose cisplatin combined with bleomycin, vincristine, and mitomycin-C (consecutive low-dose BOMP).
    Shimizu Y
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():359-77. PubMed ID: 10895181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
    N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of cervical carcinoma with methotrexate, bleomycin and vincristine.
    Behnam K; Lewis GC; Lee JH; Looka MH
    Cancer Clin Trials; 1981; 4(1):75-9. PubMed ID: 6163568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bleomycin, cisplatinum and ifosfamide infusion chemotherapy in advanced/recurrent cancer of cervix.
    Singhal RM; Jindel R; Gupta AK
    Indian J Cancer; 1993 Dec; 30(4):158-63. PubMed ID: 7515843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
    Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
    Gynecol Oncol; 2006 Nov; 103(2):618-22. PubMed ID: 16777200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination chemotherapy with vincristine, bleomycin, and methotrexate for advanced head and neck cancers.
    Woods RL; Stewart J; Fox RM; Tattersall MH
    Cancer Treat Rep; 1979; 63(11-12):1997-9. PubMed ID: 93514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer.
    Buxton EJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.